The lower levels of α-ketoglutarate, citric acid, and fumaric acid in the serum of rats in the SCP group than those in the MOD group suggest that SCP may treat NAFLD by inhibiting oxidative stress, and the results of MDA, GSH-Px, and SOD detection also confirm this. Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.